The source of the bacteria has not been determined but it has been documented that about 0.5% to 10% of healthy women are lengthened vaginal carriage of C. sordellii. There are several clinical features which are unique to C. sordellii: marked leukocytosis (leukaemoid reaction), refractory hypotension, severe tachycardia, haemoconcentration, persistent apyrexia and profound capillary leak syndrome. In terms of management, there is no hard and fast rule as with most bacterial pathogens but past data reveals C. sordellii susceptibility to beta-lactams, clindamycin, tetracycline and chloramphenicol but resistant to aminoglycosides and sulphonamides.
Pregnancy-associated infections - Toxic Shock Syndrome
 Miech RP. Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii. Ann Pharmacother 2005; 39:1483-8.
 Nakamura S, Yamakawa K, Nishida S. Antibacterial susceptibility of Clostridium sordellii strains. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 261:345-9.
New clostridium sordellii study findings have been reported by scientists at University of Bern, Vetsuisse Faculty.(Report)
Sep 06, 2010; Research findings, 'Lethal toxin of Clostridium sordellii is associated with fatal equine atypical myopathy,' are discussed in a...
Clostridium sordellii Toxic Shock Syndrome After Medical Abortion with Mifepristone and Intravaginal Misoprostol - United States and Canada, 2001-2005
Jul 29, 2005; On JuIy 22, this notice was posted as an MMWR Dispatch on the MMWR website (httpwww.cdc.gov/mmwr). On July 19, 2005, the Food and...